• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢噻肟用于治疗疑似新生儿败血症:两年经验

The use of cefotaxime for treating suspected neonatal sepsis: 2 years' experience.

作者信息

Hall M A, Beech R C, Seal D V

出版信息

J Hosp Infect. 1986 Jul;8(1):57-63. doi: 10.1016/0195-6701(86)90105-2.

DOI:10.1016/0195-6701(86)90105-2
PMID:2875103
Abstract

In 1982, the antibiotic treatment policy for suspected sepsis in neonates admitted to the Southampton special care baby unit was changed from intravenous gentamicin plus penicillin to intravenous cefotaxime with or without penicillin. Analysis of blood culture results during the first 2 years following the change indicates that a higher proportion of blood culture isolates showed sensitivity to cefotaxime compared with gentamicin. Only one baby died with proven bacterial sepsis and this was not thought to be due to treatment failure. Our data suggest that, on our unit, cefotaxime is a suitable alternative to the aminoglycosides for the management of suspected sepsis in the newborn.

摘要

1982年,南安普顿特别护理婴儿病房收治的疑似败血症新生儿的抗生素治疗方案从静脉注射庆大霉素加青霉素改为静脉注射头孢噻肟,可加用或不加用青霉素。对方案改变后的头两年血培养结果的分析表明,与庆大霉素相比,血培养分离出的菌株中对头孢噻肟敏感的比例更高。只有一名确诊为细菌性败血症的婴儿死亡,且这一情况不被认为是治疗失败所致。我们的数据表明,在我们的病房,头孢噻肟是新生儿疑似败血症治疗中氨基糖苷类药物的合适替代药物。

相似文献

1
The use of cefotaxime for treating suspected neonatal sepsis: 2 years' experience.头孢噻肟用于治疗疑似新生儿败血症:两年经验
J Hosp Infect. 1986 Jul;8(1):57-63. doi: 10.1016/0195-6701(86)90105-2.
2
A therapeutic trial of cefotaxime versus penicillin-gentamicin for severe infections in children.头孢噻肟与青霉素 - 庆大霉素治疗儿童严重感染的疗效试验。
J Antimicrob Chemother. 1984 Sep;14 Suppl B:147-52. doi: 10.1093/jac/14.suppl_b.147.
3
Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance.
Am J Dis Child. 1985 Nov;139(11):1086-9. doi: 10.1001/archpedi.1985.02140130024022.
4
A randomised prospective comparison of cefotaxime versus netilmicin/penicillin for treatment of suspected neonatal sepsis.头孢噻肟与奈替米星/青霉素治疗疑似新生儿败血症的随机前瞻性比较
Drugs. 1988;35 Suppl 2:169-77. doi: 10.2165/00003495-198800352-00036.
5
Clinical evaluation of cefotaxime versus gentamicin plus clindamycin in the treatment of polymicrobial peritonitis.头孢噻肟与庆大霉素加克林霉素治疗混合性腹膜炎的临床评估
Clin Ther. 1982;5 Suppl A:1-9.
6
Five years of cefotaxime use in a neonatal intensive care unit.
Pediatr Infect Dis J. 1990 Feb;9(2):92-6. doi: 10.1097/00006454-199002000-00006.
7
[Clinical efficacy of flomoxef in neonatal bacterial infection].氟氧头孢在新生儿细菌感染中的临床疗效
Kansenshogaku Zasshi. 1993 Mar;67(3):212-7. doi: 10.11150/kansenshogakuzasshi1970.67.212.
8
Neonatal septicemia: a reappraisal with special reference to the use of cefotaxime.新生儿败血症:特别是关于头孢噻肟使用的重新评估
Indian Pediatr. 1991 Nov;28(11):1265-70.
9
Comparison of ampicillin plus gentamicin vs. penicillin plus gentamicin in empiric treatment of neonates at risk of early onset sepsis.氨苄西林联合庆大霉素与青霉素联合庆大霉素在有早发性败血症风险的新生儿经验性治疗中的比较。
Acta Paediatr. 2010 May;99(5):665-672. doi: 10.1111/j.1651-2227.2010.01687.x. Epub 2010 Jan 20.
10
Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death.与氨苄西林和庆大霉素相比,对有败血症风险的新生儿经验性使用氨苄西林和头孢噻肟与新生儿死亡风险增加有关。
Pediatrics. 2006 Jan;117(1):67-74. doi: 10.1542/peds.2005-0179.

引用本文的文献

1
A randomised prospective comparison of cefotaxime versus netilmicin/penicillin for treatment of suspected neonatal sepsis.头孢噻肟与奈替米星/青霉素治疗疑似新生儿败血症的随机前瞻性比较
Drugs. 1988;35 Suppl 2:169-77. doi: 10.2165/00003495-198800352-00036.
2
Cefotaxime. An update of its pharmacology and therapeutic use.头孢噻肟。其药理学与治疗应用的最新进展。
Drugs. 1990 Oct;40(4):608-51. doi: 10.2165/00003495-199040040-00008.
3
Cefotaxime dosage in infants and children. Pharmacokinetic and clinical rationale for an extended dosage interval.
Clin Pharmacokinet. 1992 Apr;22(4):284-97. doi: 10.2165/00003088-199222040-00004.